Global expansion TCG has established physical offices in Raleigh, San Diego, and Heidelberg and has demonstrated a growth mindset with past expansion into Japan, signaling opportunities to pitch market entry, partner development, and regional service scaling for life science clients seeking international reach.

Senior-led expertise Clients can be engaged on high-impact engagements led personally by senior partners with over 25 years of industry experience, highlighting a premium service proposition for complex licensing, M&A, and strategic partnerships which can be packaged as a differentiator to target larger life science portfolios.

End-to-end services TCG offers a broad suite from opportunity identification and commercialization strategy to transactions, interim management, and market entry services, creating cross-sell opportunities with life science firms pursuing both strategic approvals and operational leadership in new markets.

Medtech and digital health focus With experience across medical devices, diagnostics, pharma, biotech, digital health, and health IT, there are ready-made entry points for selling advisory services around licensing deals, asset sales, strategic partnerships, and distribution agreements tailored to evolving regulatory and market needs.

Strategic partnerships Recent collaboration with MedTech Innovator and the geography-focused expansion indicate strong potential to align with accelerator programs, incubators, and corporate venturing activities to source high-potential startups and liaise on preferred partner or licensing opportunities.